Apolipoprotein A5, a Crucial Determinant of Plasma Triglyceride Levels, Is Highly Responsive to Peroxisome Proliferator-activated Receptor α Activators

This publication has 30 references indexed in Scilit:

• Two independent apolipoprotein A5 haplotypes influence human plasma triglyceride levels.
  Human Molecular Genetics, 2002
• Relative contribution of variation within the APOC3/A4/A5 gene cluster in determining plasma triglycerides
  Human Molecular Genetics, 2002
• Apolipoprotein A-V
  Journal of Biological Chemistry, 2001
• An Apolipoprotein Influencing Triglycerides in Humans and Mice Revealed by Comparative Sequencing
  Science, 2001
• Evidence that triglycerides are an independent coronary heart disease risk factor
  The American Journal of Cardiology, 2000
• Elevated Serum Triglyceride Levels and Long-Term Mortality in Patients With Coronary Heart Disease
  Circulation, 1999
• Families with Familial Combined Hyperlipidemia and Families Enriched for Coronary Artery Disease Share Genetic Determinants for the Atherogenic Lipoprotein Phenotype
  American Journal of Human Genetics, 1998
• Hypertriglyceridemia, Atherogenic Dyslipidemia, and the Metabolic Syndrome
  The American Journal of Cardiology, 1998
• An apolipoprotein CIII haplotype protective against hypertriglyceridemia is specified by promoter and 3' untranslated region polymorphisms.
  Proceedings of the National Academy of Sciences, 1993
• Familial combined hyperlipidaemia linked to the apolipoprotein AI–CIII–AIV gene cluster on chromosome 11q23q–q24
  Nature, 1991